Form 4: Director Timothy Wicks Receives RSU Grant at BrightSpring

BrightSpring Health Services director Timothy A. Wicks was granted 4,983 restricted stock units as part of director compensation.

Summary

• Director Timothy A. Wicks acquired 4,983 restricted stock units (RSUs) on May 5, 2026.
• The RSUs were granted at a price of $0 per share.
• The units are scheduled to vest fully on May 5, 2027.
• The reporting person has elected to defer settlement of these shares under the company's Non-Employee Director Deferred Compensation Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard compensatory equity grant.

Risks

• None identified; this is a standard compensatory equity grant.

Future Outlook

The RSUs will vest on May 5, 2027, with settlement deferred until the director's termination of service or a future date selected by the director.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices designed to incentivize board members and align their interests with those of shareholders.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for publicly traded healthcare services companies.
• The use of a deferred compensation plan for directors is a common practice among large-cap and mid-cap issuers to manage tax and retention objectives.

Stakeholder Impact

• Minimal impact on shareholders as this represents a standard, small-scale equity grant to a director.

Next Steps

• Vesting of the 4,983 RSUs on May 5, 2027.

Key Dates

Keywords

BrightSpring Health Services, BTSG, Form 4, Insider Trading, Director Compensation, Restricted Stock Units